The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 96,677,673 | 3,034,453 | SH | SOLE | 3,034,453 | 0 | 0 | |||
ABIVAX SA | SPONSORED ADS | 00370M103 | 61,453,363 | 4,297,438 | SH | SOLE | 4,297,438 | 0 | 0 | |||
AGENUS INC | COM NEW | 00847G705 | 18,384,573 | 31,697,539 | SH | SOLE | 31,697,539 | 0 | 0 | |||
ALECTOR INC | COM | 014442107 | 22,691,704 | 3,769,386 | SH | SOLE | 3,769,386 | 0 | 0 | |||
ALIGOS THERAPEUTICS INC | COM | 01626L105 | 5,980,715 | 6,102,770 | SH | SOLE | 6,102,770 | 0 | 0 | |||
ALKERMES PLC | SHS | G01767105 | 94,745,000 | 3,500,000 | SH | SOLE | 3,500,000 | 0 | 0 | |||
ALLAKOS INC | COM | 01671P100 | 6,300,000 | 5,000,000 | SH | SOLE | 5,000,000 | 0 | 0 | |||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 124,388,730 | 832,310 | SH | SOLE | 832,310 | 0 | 0 | |||
ALTO NEUROSCIENCE INC | COM SHS | 02157Q109 | 9,210,000 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | |||
AMGEN INC | COM | 031162100 | 156,376,000 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | |||
ANAPTYSBIO INC | COM | 032724106 | 11,923,259 | 529,452 | SH | SOLE | 529,452 | 0 | 0 | |||
ANI PHARMACEUTICALS INC | COM | 00182C103 | 56,824,929 | 822,001 | SH | SOLE | 822,001 | 0 | 0 | |||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 58,780,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | |||
APOGEE THERAPEUTICS INC | COM | 03770N101 | 154,393,651 | 2,323,456 | SH | SOLE | 2,323,456 | 0 | 0 | |||
ARGENX SE | SPONSORED ADR | 04016X101 | 118,116,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | |||
AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | 97,436,457 | 15,272,172 | SH | SOLE | 15,272,172 | 0 | 0 | |||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 104,116,736 | 1,304,721 | SH | SOLE | 1,304,721 | 0 | 0 | |||
BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | 86,913,599 | 3,490,506 | SH | SOLE | 3,490,506 | 0 | 0 | |||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 2,123,520 | 316,000 | SH | SOLE | 316,000 | 0 | 0 | |||
CYBIN INC | COM | 23256X100 | 24,040,698 | 58,139,535 | SH | SOLE | 58,139,535 | 0 | 0 | |||
DYNAVAX TECHNOLOGIES CORP | COM NEW | 268158201 | 113,448,001 | 9,141,660 | SH | SOLE | 9,141,660 | 0 | 0 | |||
DYNE THERAPEUTICS INC | COM | 26818M108 | 129,327,323 | 4,555,383 | SH | SOLE | 4,555,383 | 0 | 0 | |||
EDITAS MEDICINE INC | COM | 28106W103 | 41,012,492 | 5,527,290 | SH | SOLE | 5,527,290 | 0 | 0 | |||
ENGENE HOLDINGS INC | COM | 29286M105 | 38,137,500 | 2,250,000 | SH | SOLE | 2,250,000 | 0 | 0 | |||
FATE THERAPEUTICS INC | COM | 31189P102 | 40,902,935 | 5,572,607 | SH | SOLE | 5,572,607 | 0 | 0 | |||
GERON CORP | COM | 374163103 | 100,669,566 | 30,505,929 | SH | SOLE | 30,505,929 | 0 | 0 | |||
GUARDANT HEALTH INC | COM | 40131M109 | 123,780,000 | 6,000,000 | SH | SOLE | 6,000,000 | 0 | 0 | |||
HILLEVAX INC | COM | 43157M102 | 42,780,010 | 2,572,460 | SH | SOLE | 2,572,460 | 0 | 0 | |||
IMMUNOVANT INC | COM | 45258J102 | 15,940,203 | 493,352 | SH | SOLE | 493,352 | 0 | 0 | |||
INSMED INC | COM PAR $.01 | 457669307 | 129,781,211 | 4,783,679 | SH | SOLE | 4,783,679 | 0 | 0 | |||
INTELLIA THERAPEUTICS INC | COM | 45826J105 | 115,838,668 | 4,210,784 | SH | SOLE | 4,210,784 | 0 | 0 | |||
INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 12,137,680 | 175,400 | SH | Put | SOLE | 175,400 | 0 | 0 | ||
INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 103,800,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | |||
INVIVYD INC | COM | 00534A102 | 48,635,480 | 10,953,937 | SH | SOLE | 10,953,937 | 0 | 0 | |||
IONIS PHARMACEUTICALS INC | COM | 462222100 | 59,540,141 | 1,373,475 | SH | SOLE | 1,373,475 | 0 | 0 | |||
KYMERA THERAPEUTICS INC | COM | 501575104 | 50,742,289 | 1,262,246 | SH | SOLE | 1,262,246 | 0 | 0 | |||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 2,596,940 | 579,674 | SH | SOLE | 579,674 | 0 | 0 | |||
METAGENOMI INC | COM | 59102M104 | 4,918,748 | 466,232 | SH | SOLE | 466,232 | 0 | 0 | |||
MIND MEDICINE MINDMED INC | COM NEW | 60255C885 | 62,666,670 | 6,666,667 | SH | SOLE | 6,666,667 | 0 | 0 | |||
NEKTAR THERAPEUTICS | COM | 640268108 | 17,189,280 | 18,400,000 | SH | SOLE | 18,400,000 | 0 | 0 | |||
NEUMORA THERAPEUTICS INC. | COM | 640979100 | 13,750,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | |||
NURIX THERAPEUTICS INC | COM | 67080M103 | 44,068,101 | 2,997,830 | SH | SOLE | 2,997,830 | 0 | 0 | |||
NUVALENT INC | COM | 670703107 | 20,613,106 | 274,512 | SH | SOLE | 274,512 | 0 | 0 | |||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 115,765,286 | 12,721,460 | SH | SOLE | 12,721,460 | 0 | 0 | |||
OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 36,511,743 | 3,225,419 | SH | SOLE | 3,225,419 | 0 | 0 | |||
PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 26,250,000 | 7,000,000 | SH | SOLE | 7,000,000 | 0 | 0 | |||
PLIANT THERAPEUTICS INC | COM | 729139105 | 85,675,000 | 5,750,000 | SH | SOLE | 5,750,000 | 0 | 0 | |||
PRIME MEDICINE INC | COM | 74168J101 | 2,126,012 | 303,716 | SH | SOLE | 303,716 | 0 | 0 | |||
PYXIS ONCOLOGY INC | COMMON STOCK | 747324101 | 17,824,266 | 4,184,100 | SH | SOLE | 4,184,100 | 0 | 0 | |||
REGULUS THERAPEUTICS INC | COM | 75915K309 | 9,407,710 | 3,266,566 | SH | SOLE | 3,266,566 | 0 | 0 | |||
RELMADA THERAPEUTICS INC | COM | 75955J402 | 5,766,158 | 1,240,034 | SH | SOLE | 1,240,034 | 0 | 0 | |||
REPARE THERAPEUTICS INC | COM | 760273102 | 12,643,260 | 2,684,344 | SH | SOLE | 2,684,344 | 0 | 0 | |||
SCHOLAR ROCK HLDG CORP | COM | 80706P103 | 12,076,800 | 680,000 | SH | SOLE | 680,000 | 0 | 0 | |||
SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | 35,507,830 | 1,643,881 | SH | SOLE | 1,643,881 | 0 | 0 | |||
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 171,278,365 | 3,479,853 | SH | SOLE | 3,479,853 | 0 | 0 | |||
SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | 46,025,021 | 1,213,420 | SH | SOLE | 1,213,420 | 0 | 0 | |||
STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | 1,720,272 | 40,137 | SH | SOLE | 40,137 | 0 | 0 | |||
SYROS PHARMACEUTICALS INC | COM NEW | 87184Q206 | 4,432,395 | 828,485 | SH | SOLE | 828,485 | 0 | 0 | |||
TERNS PHARMACEUTICALS INC | COM | 880881107 | 40,016,000 | 6,100,000 | SH | SOLE | 6,100,000 | 0 | 0 | |||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 56,822,700 | 7,370,000 | SH | SOLE | 7,370,000 | 0 | 0 | |||
TOURMALINE BIO INC | COM | 89157D105 | 36,534,660 | 1,595,400 | SH | SOLE | 1,595,400 | 0 | 0 | |||
ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 7,833,835 | 167,784 | SH | SOLE | 167,784 | 0 | 0 | |||
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 51,285,507 | 3,187,415 | SH | SOLE | 3,187,415 | 0 | 0 | |||
VIGIL NEUROSCIENCE INC | COM | 92673K108 | 5,438,715 | 1,594,931 | SH | SOLE | 1,594,931 | 0 | 0 | |||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 60,515,488 | 3,456,053 | SH | SOLE | 3,456,053 | 0 | 0 | |||
ZURA BIO LTD | CLASS A ORD SHS | G9TY5A101 | 6,484,110 | 2,523,000 | SH | SOLE | 2,523,000 | 0 | 0 |